Aspira Pathlab & Diagnostics informs about compliance certificate

10 Apr 2023 Evaluate
Aspira Pathlab & Diagnostics has informed that it enclosed Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, for the quarter ended 31st March, 2023, as received from Link Intime India, the Registrar and Share Transfer Agent (RTA) of the Company.

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

55.03 2.03 (3.83%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7036.65
Max Healthcare Inst 1006.75
Narayana Hrudayalay 1249.35
Aster DM Healthcare 444.55
Global Health 1115.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.